MUP is currently the one of the largest healthcare company in the MENA region with offices in more than 30 countries and major manufacturing Plant in Egypt. In recent years, MUP has focused its business on three strategic priorities which aim to increase growth, increase production capacity and improve long-term financial performance. We are succeeding in our strategy to create a more balanced business capable of addressing the market challenges we face, delivering sustainable financial performance and providing new value to patients and consumers. In 2021, we delivered underlying sales growth, strong cash generation and increased shareholder returns. 


Annual Report

We made significant progress towards our three strategic priorities. On this page, we present our corporate reporting documents for 2021.

Annual Report 2021


We recommend downloading a copy of our annual report 2021. A printed copy of the annual report can be obtained free of charge from our office or any agent around the world.



Medical Union Pharmaceuticals newsletter

Subscribe with your e-mail address to stay up-to-date. We will send you all new MUP news, product launches, Pharmacovigilance cases and our activity to be up-to-date

Go to top